Analytical development is the CMC work that builds and qualifies the test methods proving your drug's identity, purity, potency, and impurities. You need it the moment material moves toward GMP and the clinic, since you cannot release a batch you cannot measure. On BioBridgeX, buyers source and compare qualified CDMOs for this exact work in one place.
Analytical Development CDMOs (147)
Apeloa Pharmaceutical
AAPharmaSyn
Famar Group
CDMO · Formulation Development, LNP / Delivery Formulation, Process Development
Singota Solutions
CDMO · Aseptic Fill-Finish, Drug Product Manufacturing, QC & Release Testing
Symbiosis Pharmaceutical Services
CDMO · Aseptic Fill-Finish, Drug Product Manufacturing, QC & Release Testing
Lifecore Biomedical
CDMO · Formulation Development, LNP / Delivery Formulation, Process Development
Grand River Aseptic Manufacturing (GRAM)
CDMO · Formulation Development, LNP / Delivery Formulation, Process Development
Curia Global
CRO & CDMO · Drug Substance: Small Molecule / API, Drug Substance: Biologics, Formulation Development
Aenova Group
CDMO · Formulation Development, LNP / Delivery Formulation, Process Development
Simtra BioPharma Solutions
CDMO · Formulation Development, LNP / Delivery Formulation, Process Development
Vetter Pharma
CDMO · Formulation Development, LNP / Delivery Formulation, Process Development
PCI Pharma Services
CDMO · Aseptic Fill-Finish, Drug Product Manufacturing, Formulation Development
LOTTE BIOLOGICS
CDMO · Drug Substance: Biologics, ADC / Bioconjugation, Cell Line / Strain Development
ChemPartner
CRO & CDMO · ADC / Bioconjugation, Medicinal & Synthetic Chemistry, Drug Substance: Biologics
Mabion
CDMO · Drug Substance: Biologics, Cell Line / Strain Development, Process Development
NJ Bio
CRO & CDMO · ADC / Bioconjugation, Medicinal & Synthetic Chemistry, Assay Development & Screening
GeneQuantum Healthcare
CDMO · ADC / Bioconjugation, Medicinal & Synthetic Chemistry, Process Development
Axplora (formerly Novasep)
CDMO · ADC / Bioconjugation, Drug Substance: Small Molecule / API, Medicinal & Synthetic Chemistry
AsymBio (Asymchem)
CDMO · ADC / Bioconjugation, Drug Substance: Biologics, Drug Substance: Small Molecule / API
BSP Pharmaceuticals
CDMO · ADC / Bioconjugation, Aseptic Fill-Finish, Drug Product Manufacturing
Ajinomoto Bio-Pharma Services (Aji Bio-Pharma)
CDMO · ADC / Bioconjugation, Drug Substance: Biologics, Peptide / Oligo Synthesis
Levena Biopharma
CRO & CDMO · ADC / Bioconjugation, Medicinal & Synthetic Chemistry, Process Development
Celonic
CDMO · Drug Substance: Biologics, Cell Line / Strain Development, Process Development
CARBOGEN AMCIS
CDMO · ADC / Bioconjugation, Drug Substance: Small Molecule / API, Medicinal & Synthetic Chemistry
Cerbios-Pharma
CDMO · ADC / Bioconjugation, Drug Substance: Small Molecule / API, Drug Substance: Biologics
MilliporeSigma (SAFC)
CDMO · ADC / Bioconjugation, Drug Substance: Small Molecule / API, Process Development
FUJIFILM Biotechnologies
CDMO · Drug Substance: Biologics, ADC / Bioconjugation, Cell Line / Strain Development
WuXi XDC
CDMO · ADC / Bioconjugation, Drug Substance: Biologics, Drug Substance: Small Molecule / API
MabPlex
CDMO · ADC / Bioconjugation, Drug Substance: Biologics, Cell Line / Strain Development
WuXi STA (STA Pharmaceutical)
CDMO · Peptide / Oligo Synthesis, Drug Substance: Small Molecule / API, ADC / Bioconjugation
CPC Scientific
CDMO · Peptide / Oligo Synthesis, Process Development, Analytical Development
Senn Chemicals (Granules India)
CDMO · Peptide / Oligo Synthesis, Process Development, Analytical Development
Recipharm
CDMO · mRNA / RNA Manufacturing, LNP / Delivery Formulation, Drug Product Manufacturing
Phosphorex
CDMO · LNP / Delivery Formulation, Formulation Development, Process Development
Ascendia Pharmaceutical Solutions
CDMO · LNP / Delivery Formulation, Formulation Development, Drug Product Manufacturing
Evonik (Health Care)
CDMO · LNP / Delivery Formulation, Formulation Development, Drug Product Manufacturing
Merck Millipore (MilliporeSigma / Sigma-Aldrich CTDMO)
CDMO · mRNA / RNA Manufacturing, LNP / Delivery Formulation, Plasmid DNA Manufacturing
Fujifilm (Toyama Chemical / FUJIFILM Diosynth LNP)
CDMO · mRNA / RNA Manufacturing, LNP / Delivery Formulation, Aseptic Fill-Finish
Ajinomoto Bio-Pharma Services
CRO & CDMO · Peptide / Oligo Synthesis, ADC / Bioconjugation, Drug Substance: Small Molecule / API
CSBio
CDMO · Peptide / Oligo Synthesis, Process Development, Analytical Development
Bio-Synthesis Inc
CDMO · Peptide / Oligo Synthesis, mRNA / RNA Manufacturing, ADC / Bioconjugation
Northern RNA
CDMO · mRNA / RNA Manufacturing, LNP / Delivery Formulation, Plasmid DNA Manufacturing
TriLink BioTechnologies (Maravai LifeSciences)
CDMO · mRNA / RNA Manufacturing, Peptide / Oligo Synthesis, Process Development
Polymun Scientific
CDMO · LNP / Delivery Formulation, mRNA / RNA Manufacturing, Formulation Development
Agilent Technologies
CDMO · Peptide / Oligo Synthesis, Process Development, Analytical Development
ST Pharm
CDMO · Peptide / Oligo Synthesis, mRNA / RNA Manufacturing, Process Development
Nitto Avecia Pharma Services
CDMO · Peptide / Oligo Synthesis, Process Development, Analytical Development
WuXi TIDES (WuXi AppTec)
CRO & CDMO · Peptide / Oligo Synthesis, ADC / Bioconjugation, Medicinal & Synthetic Chemistry
Kaneka Eurogentec
CDMO · Peptide / Oligo Synthesis, Plasmid DNA Manufacturing, Drug Substance: Biologics
PolyPeptide Group
CDMO · Peptide / Oligo Synthesis, Process Development, Analytical Development
Advanced BioScience Laboratories (ABL)
CDMO · Viral Vector Manufacturing, Process Development, Analytical Development
Merck KGaA (MilliporeSigma / Sigma-Aldrich CTDMO)
CRO & CDMO · Viral Vector Manufacturing, Cell Therapy Manufacturing, mRNA / RNA Manufacturing
Vernal Biosciences
CDMO · mRNA / RNA Manufacturing, LNP / Delivery Formulation, Plasmid DNA Manufacturing
Ascend Advanced Therapies
CDMO · Viral Vector Manufacturing, Process Development, Analytical Development
IDT Biologika
CDMO · Viral Vector Manufacturing, Process Development, Analytical Development
Vibalogics (ReciBioPharm / Recipharm)
CDMO · Viral Vector Manufacturing, Process Development, Analytical Development
VectorBuilder
CRO & CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, Process Development
Pharmaron (Biologics / CGT)
CRO & CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, Cell Therapy Manufacturing
Esco Aster
CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, Cell Therapy Manufacturing
3PBIOVIAN (3P Biopharmaceuticals + Biovian)
CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, Cell Therapy Manufacturing
Eurogentec (Kaneka)
CDMO · Plasmid DNA Manufacturing, Peptide / Oligo Synthesis, mRNA / RNA Manufacturing
PackGene Biotech
CRO & CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, mRNA / RNA Manufacturing
SK pharmteco
CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, Cell Therapy Manufacturing
The Center for Breakthrough Medicines
CDMO · Viral Vector Manufacturing, Cell Therapy Manufacturing, Plasmid DNA Manufacturing
ElevateBio BaseCamp
CDMO · Cell Therapy Manufacturing, Viral Vector Manufacturing, Process Development
RoslinCT
CDMO · Cell Therapy Manufacturing, Process Development, Analytical Development
Minaris Advanced Therapies
CDMO · Cell Therapy Manufacturing, Viral Vector Manufacturing, Process Development
Cellipont Bioservices
CDMO · Cell Therapy Manufacturing, Process Development, Analytical Development
Genezen
CDMO · Viral Vector Manufacturing, Cell Therapy Manufacturing, Plasmid DNA Manufacturing
Viralgen (AskBio)
CDMO · Viral Vector Manufacturing, Process Development, Analytical Development
Andelyn Biosciences
CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, Process Development
Forge Biologics (Ajinomoto)
CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, Process Development
Aldevron (Danaher)
CDMO · Plasmid DNA Manufacturing, mRNA / RNA Manufacturing, Process Development
National Resilience
CDMO · Viral Vector Manufacturing, Cell Therapy Manufacturing, mRNA / RNA Manufacturing
FUJIFILM Biotechnologies (formerly FUJIFILM Diosynth)
CDMO · Viral Vector Manufacturing, Cell Therapy Manufacturing, Process Development
Oxford Biomedica
CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, Process Development
WuXi Advanced Therapies
CRO & CDMO · Viral Vector Manufacturing, Cell Therapy Manufacturing, Plasmid DNA Manufacturing
Catalent
CDMO · Viral Vector Manufacturing, Cell Therapy Manufacturing, Plasmid DNA Manufacturing
Aldevron
CDMO · Process Development, Analytical Development, Plasmid DNA Manufacturing
Polpharma Biologics
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Bora Biologics
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Binex
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
GenScript ProBio
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Bionova Scientific
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Wacker Biotech
CDMO · Process Development, Analytical Development, Drug Substance: Biologics
Richter BioLogics (Richter-Helm)
CDMO · Process Development, Analytical Development, Drug Substance: Biologics
3PBIOVIAN
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Avid Bioservices
CDMO · Process Development, Analytical Development, Drug Substance: Biologics
Cytovance Biologics
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
GBI (Goodwin Biotechnology)
CDMO · Process Development, Analytical Development, Drug Substance: Biologics
BioVectra
CDMO · Process Development, Analytical Development, Drug Substance: Biologics
ProBioGen
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Just - Evotec Biologics
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Northway Biotech
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Wheeler Bio
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Rentschler Biopharma
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
KBI Biopharma
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
AGC Biologics
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
FUJIFILM Diosynth Biotechnologies
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Catalent Biologics
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Boehringer Ingelheim BioXcellence
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
WuXi Biologics
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Samsung Biologics
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Teva API (TAPI)
CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
Almac Group
CRO & CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Onyx Scientific (IPCA)
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Laurus Labs (Laurus Synthesis)
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Navin Molecular (Navin Fluorine)
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
F.I.S. (Fabbrica Italiana Sintetici)
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
PROCOS
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Sumitomo Chemical (Pharmaceuticals/CDMO)
CDMO · Process Development, Drug Substance: Small Molecule / API, Analytical Development
Fermion (Orion Corporation)
CDMO · Process Development, Drug Substance: Small Molecule / API, Analytical Development
Minakem (Minafin Group)
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Curia (formerly AMRI)
CRO & CDMO · Target ID & Validation, Hit-to-Lead, Lead Optimization
Bachem
CDMO · Peptide / Oligo Synthesis, Process Development, Analytical Development
AMPAC Fine Chemicals (SK pharmteco)
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Veranova
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Pfizer CentreOne
CRO & CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
Noramco
CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
Thermo Fisher Scientific (Patheon)
CRO & CDMO · Process Development, Drug Substance: Small Molecule / API, Analytical Development
Divi's Laboratories
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Dr. Reddy's Custom Pharma Services (CPS)
CRO & CDMO · Process Development, Drug Substance: Small Molecule / API, Analytical Development
Piramal Pharma Solutions
CRO & CDMO · Hit-to-Lead, Lead Optimization, Medicinal & Synthetic Chemistry
EUROAPI
CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
Seqens
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Olon Group
CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
Fareva
CRO & CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
DOTTIKON ES
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Hovione
CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
CordenPharma
CRO & CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
Sterling Pharma Solutions
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
WuXi STA (WuXi AppTec)
CRO & CDMO · Medicinal & Synthetic Chemistry, Process Development, Analytical Development
Asymchem
CRO & CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Siegfried
CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
Cambrex
CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
Lonza
CRO & CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
Eurofins (Pharma Discovery & Bioanalytical Services)
CRO & CDMO · Bioanalytical Services, Central Laboratory Services, Genetic Toxicology
Nucro-Technics
CRO & CDMO · GLP Toxicology, Genetic Toxicology, Bioanalytical Services
Abzena
CRO & CDMO · Assay Development & Screening, Hit-to-Lead, Lead Optimization
Aurigene Pharmaceutical Services
CRO & CDMO · Target ID & Validation, Assay Development & Screening, Hit-to-Lead
Syngene International
CRO & CDMO · GLP Toxicology, Safety Pharmacology, DMPK / ADME
Aragen Life Sciences
CRO & CDMO · DMPK / ADME, GLP Toxicology, Safety Pharmacology
Sai Life Sciences
CRO & CDMO · DMPK / ADME, In Vitro / Early Toxicology, GLP Toxicology
Frontage Laboratories
CRO & CDMO · GLP Toxicology, Safety Pharmacology, Toxicokinetics (TK)
Charles River Laboratories
CRO & CDMO · GLP Toxicology, Safety Pharmacology, Genetic Toxicology
Pharmaron
CRO & CDMO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
What is Analytical Development and when do you need it?
Analytical development is the part of CMC that builds the test methods used to describe your drug and prove it is what you say it is. Every release specification, every stability data point, every impurity limit rests on an assay that someone had to develop, qualify, and eventually validate. The deliverable is not material; it is a set of methods plus the data that shows they are accurate, precise, specific, and capable of detecting the things that would make a batch fail. Put plainly, you cannot release a batch you cannot measure, so analytical work tends to gate everything else in manufacturing.
You need it the moment a program moves from bench chemistry toward GMP material and the clinic. Early on, a method can be a development-grade HPLC run that tells your process chemist whether a step worked. As you approach a clinical batch, the same assays have to mature into qualified, then validated, methods that release drug substance and drug product and feed your IND Module 3. The work runs in parallel with process development and formulation, because the process keeps changing what the methods have to see, and stability cannot start until the stability-indicating methods exist.
What the assays look like depends heavily on modality. A small-molecule API leans on HPLC or UPLC for assay and related substances, Karl Fischer for water, residual-solvent GC under ICH Q3C, elemental impurities by ICP-MS under Q3D, and forced-degradation studies to prove the method is stability-indicating. A monoclonal antibody adds size-exclusion chromatography for aggregates, capillary electrophoresis and icIEF for charge variants, peptide mapping by LC-MS for identity and post-translational modifications, host cell protein ELISA, and residual host cell DNA by qPCR or ddPCR. Cell and gene therapy products carry their own potency and vector-characterization assays. The supplier pool that is excellent at one of these is rarely the right pool for another.
What does an Analytical Development CDMO actually do?
An analytical development group takes your molecule and builds the methods that will follow it through development, then runs them to generate the data a regulator expects. The work is phase-appropriate: methods are qualified for early clinical use and fully validated under ICH Q2(R2) for later phases and registration, against specifications shaped by ICH Q6A for small molecules or Q6B for biologics. A good group also owns method transfer, so an assay that worked at one site reproduces at the next without a surprise out-of-specification result.
Concretely, this is what buyers are sourcing under the Analytical Development heading:
- Method development: building identity, assay or potency, purity and related-substances, and impurity methods (HPLC, UPLC, CE, icIEF, GC, ICP-MS, ELISA, qPCR or ddPCR, mass spec) suited to your modality.
- Method qualification and validation: phase-appropriate validation under ICH Q2(R2) for specificity, accuracy, precision, linearity, range, detection and quantitation limits, and robustness.
- Release and characterization testing: the panel that releases a batch (identity, purity, potency, residuals, sterility-adjacent attributes) and the deeper structural characterization a biologic needs.
- Forced-degradation and stability-indicating method development: stressing the molecule (heat, light, acid, base, oxidation) so the method can detect real degradation products before stability runs.
- Impurity profiling and reference standards: characterizing process and degradation impurities under ICH Q3A/Q3B/Q3C/Q3D, and qualifying reference standards the methods depend on.
- Stability program support: protocol design and testing across ICH Q1A(R2) conditions to support shelf life and storage claims.
- Method transfer and tech transfer support: moving validated methods between your site, the drug-substance maker, and the release lab without re-developing them.
How do you choose an Analytical Development CDMO?
Start with modality fit, because the assay menu changes completely across small molecules, antibodies, peptides and oligos, viral vector, mRNA, and cell therapy. A lab that runs flawless small-molecule HPLC and residual-solvent GC may have never qualified a cell-based potency assay or a residual host cell DNA method, and those are exactly the assays that hold up an advanced-therapy filing. Ask to see relevant methods they have already validated in your modality, not a general capability slide.
Then weigh the quality grade you need now against where the program is going. Early development methods can run non-GMP, but release and stability testing for clinical material must sit under GMP in a quality system with documented OOS handling, change control, and an inspection history you can cite. The other practical filters decide whether the work runs on time and survives a transfer later:
- Quality and GxP status: GMP for release and stability testing, a working quality unit, documented OOS and deviation handling, and a clean inspection record from the agencies you plan to file with (FDA, EMA, PMDA).
- Capacity and lead time: real instrument and analyst availability, not a booked-out queue, plus a realistic timeline for development, validation, and the first release campaign.
- Modality and indication fit: demonstrated, validated methods in your specific modality and the impurity and potency assays it actually requires.
- Region and regulatory track record: experience supporting submissions in your target markets, and familiarity with USP, Ph. Eur., and JP compendial methods where they apply.
- Data quality and integrity: ALCOA-aligned records, validated software and audit trails (21 CFR Part 11), and stability-indicating methods backed by real forced-degradation data.
- IP and confidentiality: clear ownership of methods, data, and any reference standards developed, with confidentiality terms that protect a molecule you may not want disclosed.
- Method transferability: methods documented well enough to move cleanly to your drug-substance CDMO and release lab, so you avoid re-developing an assay mid-program.
Frequently asked questions
What is the difference between analytical development and process development?
When does a method need to be validated versus just qualified?
What is a stability-indicating method and why does it matter?
Do biologics need different analytical development than small molecules?
Does analytical development need to run under GMP?
How does sourcing an Analytical Development CDMO through BioBridgeX work?
Source Analytical Development with one contract
Compare transparent quotes from qualified Analytical Development CDMOs, then contract once. Free for buyers.
Compare quotes